Notably, the PI3K-Akt pathway is implicated in the enrichment results of three key genes in our study, suggesting that PIK-93 may play a role in the treatment of SLE by targeting F2R and modulating the PI3K-Akt pathway. This evidence concerns the gene F2R and systemic lupus erythematosus.